Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Cancer Research and Clinical Oncology|May 5, 2023
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa projectFriederike Braulke, Servet Para, Bernd Alt-Epping, et al.
Blood Cancer Journal|May 26, 2023
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcomeJulia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, et al.
Cancer Cell|April 30, 2015
Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsChantana Polprasert, Isabell Schulze, Mikkael A Sekeres, et al.
Leukemia|June 12, 2019
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemiaLinus Angenendt, Eike Bormann, Caroline Pabst, et al.
Leukemia|January 16, 2024
Prognostic impact of CEBPA mutational subgroups in adult AMLJulia-Annabell Georgi, Sebastian Stasik, Michael Kramer, et al.
Leukemia|February 19, 2021
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trialChristoph Röllig, Hubert Serve, Richard Noppeney, et al.
Blood|July 28, 2021
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcomeFranziska Taube, Julia Annabell Georgi, Michael Kramer, et al.
Leukemia|September 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)Monica Cusan, Karilyn Larkin, Deedra Nicolet, et al.
Journal of Hematology & Oncology|September 5, 2022
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantationDesiree Kunadt, Sebastian Stasik, Klaus H Metzeler, et al.
Leukemia|November 28, 2023
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, et al.
Pageof 8